Abstract:You have accessJournal of UrologyCME1 May 2022PD18-09 A NOVEL PROGNOSTIC BIOMARKER TO PREDICT TUMOR MUTATION BURDEN BASED ON DEEP LEARNING FROM SLIDE IMAGES Jian Lu, Ji De He, Ye Yan, Zhen Yu Liu, Xue Hua Zhu, Jie Tian, Ze Nan Liu, Jian Gang Liu, and Xiang Yu Liu Jian LuJian Lu More articles by this author , Ji De HeJi De He More articles by this author , Ye YanYe Yan More articles by this author , Zhen Yu LiuZhen Yu Liu More articles by this author , Xue Hua ZhuXue Hua Zhu More articles by this author , Jie TianJie Tian More articles by this author , Ze Nan LiuZe Nan Liu More articles by this author , Jian Gang LiuJian Gang Liu More articles by this author , and Xiang Yu LiuXiang Yu Liu More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002556.09AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: We developed a classification model based on the clustering deep learning features of hematoxylin and eosin (H&E)-stained WSIs, to predict tumor mutation burden(TMB) level of patients with ccRCC. Due to the potential prognostic value of TMB, we further analyzed the relationship between the obtained deep TMB signature and the patient's survival outcome. METHODS: 1. Patient cohorts and TMB threshold definition This study included two independent cohorts. The in-house discovery cohort consisted of 264 ccRCC patients associated with 295 WSIs, the matched data came from the next-generation sequencing (NGS) test for clinical purposes. The external validation cohort consisted of 302 ccRCC patients associated with 304 WSIs, from The Cancer Genome Atlas (TCGA) data portal. We chose to perform a binary classification task that predicted high- and low-TMB. We used segmented regression (“broken-stick analysis”) to define the threshold in the two independent cohorts. 2. WSIs processing In this study, we chose to focus on the tumor regions in the WSIs to avoid interference from redundant information. 3. Deep learning features-based patient-level TMB prediction We used a ResNet50 model pre-trained on ImageNet to extract a 1,024-dimensional feature vector of each tile. Based on the top features (n=64), logistic regression with L2 regularization was applied to construct the deep TMB score for each patient. Hyperparameter selection was carried out through the 5-fold cross-validation of the training cohort. 4. Statistical analysis We used Python (version 3.7.3) for data processing and model training, and used R software (version 3.6.1) for statistical analyses. RESULTS: 1. Patient clinical characteristics and TMB distribution We did not choose to divide high- and low-TMB by quantile. In the two cohorts, 44 (16.7%) and 40 (13.2%) patients were divided into high-TMB group. 2. Deep learning features in WSI can be used to predict ccRCC TMB We totally obtained 1,104,028 tiles in the discovery cohort and 1,449,222 tiles in the external validation cohort. The AUC of the model in the training cohort, internal validation cohort and external validation cohort are 0.797, 0.813, and 0.655, respectively. 3. Prognostic value of TMB signatures The results of K-M survival analysis revealed that the OS of patients in the high-TMB groups was significantly lower than those in the low-TMB groups (P = 0.0067, Log-Rank test). CONCLUSIONS: We constructed a TMB-level prediction model based on WSI's deep learning features, and obtained patient-level deep TMB signature. The model had good classification performance and was validated on the internal and external validation cohorts.The deep TMB signature maintained a good prognostic risk stratification performance in the advanced and metastatic ccRCC patient population, which can provide further support for the formulation of treatment plans. Source of Funding: the National Natural Science Foundation of China © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 207Issue Supplement 5May 2022Page: e347 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information Jian Lu More articles by this author Ji De He More articles by this author Ye Yan More articles by this author Zhen Yu Liu More articles by this author Xue Hua Zhu More articles by this author Jie Tian More articles by this author Ze Nan Liu More articles by this author Jian Gang Liu More articles by this author Xiang Yu Liu More articles by this author Expand All Advertisement PDF downloadLoading ...

Development of Prognostic Biomarkers by TMB-Guided WSI Analysis: A Two-Step Approach

Pan-cancer Computational Histopathology Reveals Tumor Mutational Burden Status Through Weakly-Supervised Deep Learning.

A Novel Prognostic Biomarker to Predict Tumor Mutation Burden Based on Deep Learning from Slide Images

Blood Tumor Mutation Burden Can Predict the Clinical Response to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer Patients

Tumor Mutation Burden–Related Histopathologic Features for Predicting Overall Survival in Gliomas Using Graph Deep Learning

Deep learning-based approach to reveal tumor mutational burden status from whole slide images across multiple cancer types

Predicting Tumor Mutational Burden From Lung Adenocarcinoma Histopathological Images Using Deep Learning

Exploring prognostic indicators in the pathological images of hepatocellular carcinoma based on deep learning

Tumor mutation burden-related histopathological features for predicting overall survival in gliomas using graph deep learning

Ensemble transformer-based multiple instance learning to predict pathological subtypes and tumor mutational burden from histopathological whole slide images of endometrial and colorectal cancer

Harnessing TME depicted by histological images to improve cancer prognosis through a deep learning system

Exploring prognostic indicators in the pathological images of ovarian cancer based on a deep survival network

Predicting gastric cancer tumor mutational burden from histopathological images using multimodal deep learning

Multi-Level Analysis and Identification of Tumor Mutational Burden Genes across Cancer Types

Exploring prognostic biomarkers in pathological images of colorectal cancer patients via deep learning

TSDLPP: A Novel Two-Stage Deep Learning Framework for Prognosis Prediction Based on Whole Slide Histopathological Images.

A Novel Approach Combined Transfer Learning and Deep Learning to Predict TMB from Histology Image

Spatial heterogeneity and organization of tumor mutation burden with immune infiltrates within tumors based on whole slide images correlated with patient survival in bladder cancer

MGCT: Mutual-Guided Cross-Modality Transformer for Survival Outcome Prediction using Integrative Histopathology-Genomic Features

Prediction of Tumor Mutation Load in Colorectal Cancer Histopathological Images Based on Deep Learning

Predicting Tumor Mutational Burden from Liver Cancer Pathological Images Using Convolutional Neural Network.